GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atara Biotherapeutics Inc (FRA:AT2) » Definitions » E10

Atara Biotherapeutics (FRA:AT2) E10 : €-3.90 (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Atara Biotherapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Atara Biotherapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was €-0.514. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-3.90 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-04-30), Atara Biotherapeutics's current stock price is €0.6458. Atara Biotherapeutics's E10 for the quarter that ended in Dec. 2023 was €-3.90. Atara Biotherapeutics's Shiller PE Ratio of today is .


Atara Biotherapeutics E10 Historical Data

The historical data trend for Atara Biotherapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atara Biotherapeutics E10 Chart

Atara Biotherapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -3.43 -3.90

Atara Biotherapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.43 -3.51 -3.63 -3.92 -3.90

Competitive Comparison of Atara Biotherapeutics's E10

For the Biotechnology subindustry, Atara Biotherapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atara Biotherapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atara Biotherapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Atara Biotherapeutics's Shiller PE Ratio falls into.



Atara Biotherapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Atara Biotherapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.514/129.4194*129.4194
=-0.514

Current CPI (Dec. 2023) = 129.4194.

Atara Biotherapeutics Quarterly Data

per share eps CPI Adj_EPS
201403 -0.373 99.695 -0.484
201406 -0.171 100.560 -0.220
201409 -0.237 100.428 -0.305
201412 -0.543 99.070 -0.709
201503 -0.388 99.621 -0.504
201506 -0.552 100.684 -0.710
201509 -0.383 100.392 -0.494
201512 -0.689 99.792 -0.894
201603 -0.521 100.470 -0.671
201606 -0.587 101.688 -0.747
201609 -0.784 101.861 -0.996
201612 -0.597 101.863 -0.759
201703 -0.823 102.862 -1.035
201706 -0.837 103.349 -1.048
201709 -0.856 104.136 -1.064
201712 -0.972 104.011 -1.209
201803 -0.852 105.290 -1.047
201806 -0.984 106.317 -1.198
201809 -1.106 106.507 -1.344
201812 -1.538 105.998 -1.878
201903 -1.274 107.251 -1.537
201906 -1.416 108.070 -1.696
201909 -1.189 108.329 -1.420
201912 -1.224 108.420 -1.461
202003 -1.086 108.902 -1.291
202006 -1.012 108.767 -1.204
202009 -0.781 109.815 -0.920
202012 -0.781 109.897 -0.920
202103 -0.722 111.754 -0.836
202106 -0.755 114.631 -0.852
202109 -0.765 115.734 -0.855
202112 -0.850 117.630 -0.935
202203 -0.790 121.301 -0.843
202206 0.170 125.017 0.176
202209 -0.828 125.227 -0.856
202212 -0.680 125.222 -0.703
202303 -0.672 127.348 -0.683
202306 -0.628 128.729 -0.631
202309 -0.618 129.860 -0.616
202312 -0.514 129.419 -0.514

Add all the adjusted EPS together and divide 10 will get our e10.


Atara Biotherapeutics  (FRA:AT2) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Atara Biotherapeutics E10 Related Terms

Thank you for viewing the detailed overview of Atara Biotherapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Atara Biotherapeutics (FRA:AT2) Business Description

Traded in Other Exchanges
Address
2380 Conejo Spectrum St, Suite 200, Thousand Oaks, CA, USA, 91320
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

Atara Biotherapeutics (FRA:AT2) Headlines

No Headlines